/
BMY
$64.60+$1.76 (+2.79%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$132.4B
2,042M shares
52-week range
$42.52 – $65.56
96% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
CS
Change$-3.16
Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
www.bms.com- Employees
- 32,500
- IPO / List date
- Jun 23, 1952
- HQ
- PRINCETON, NJ
Held by traders on TradeandTell
No one on the platform currently holds BMY.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 977,051 | $59.3M |
| Bridgewater Associatesas of 2026-03-31 | 241,689 | $14.7M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 3.89% ($2.51/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-02 | $0.6300 | 2026-08-03 |
| 2026-04-02 | $0.6300 | 2026-05-01 |
| 2026-01-02 | $0.6300 | 2026-02-02 |
| 2025-10-03 | $0.6200 | 2025-11-03 |
| 2025-07-03 | $0.6200 | 2025-08-01 |
| 2025-04-04 | $0.6200 | 2025-05-01 |
| 2025-01-03 | $0.6200 | 2025-02-03 |
| 2024-10-04 | $0.6000 | 2024-11-01 |
| 2024-07-05 | $0.6000 | 2024-08-01 |
| 2024-04-04 | $0.6000 | 2024-05-01 |
Recent trades on TradeandTell
No one on the platform has traded BMY yet.
